JPRN-UMIN000020357已完成未知
Phase I study to optimize the safe starting dose of weekly paclitaxel - Optimizing the starting dose of paclitaxel
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe co-morbidity are excluded
研究者
相似试验
Enrolling By Invitation
1 期
Engineered T cells for the treatment of B-cell leukemiaB-cell leukemiaCAR-CD19 T cellTCTR20160921001TCELS15
尚未招募
不适用
GEN-001 multiple dose phase 1 studyKCT0006311Jeonbuk National University Hospital12
招募中
1 期
Phase 1 study to examine the safety and dose-dependent effect of rapamycin topical medicine on perspiration in healthy volunteershyperhidrosisJPRN-UMIN000016525Department of Dermatology Graduate School of Medicine, Osaka University12
招募中
1 期
Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasisiver resection for liver metastasis of colorectal cancerJPRN-UMIN000021146Oita university, faculty of medicine, department gastroenterology and pediatric surgery18
已完成
1 期
Clinical trial to evaluate safety, tolerability and pharmacokinetic of herbal (ICB-014-A002) capsule in healthy adult volunteers.CTRI/2018/01/011259Indian Institute of Integrative Medicine Council of Scientific Industrial Research38